Motilal Oswal Financial Services has reiterated its BUY recommendation for Sun Pharma, assigning a 12-month target price of Rs 1,960, with the stock currently trading at Rs 1,690.
Prabhudas Lilladher research has issued an Accumulate Call on telecom major Bharti Airtel, driven by an impressive Q2FY26 performance that surpassed expectations.
There’s a quiet revolution happening in India’s financial world, and it’s not just about new banking apps or UPI limits being raised. It’s about how people think about money altogether.
Motilal Oswal, a leading research house, has reiterated a BUY call on Mahindra & Mahindra (M&M) with a target price of Rs 4,122, citing robust earnings, margin expansion, and strong growth
Shriram Finance Limited (SFL) continues to display robust performance, endorsed by a recent BUY call from Axis Direct with a target price of Rs 860 per share.